TY  - GEN
AU  - Westerhout,Cynthia M
AU  - Boersma,Eric
TI  - Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
SN  - 1474-0338
PY  - 2003///0912
KW  - Abciximab
KW  - Acetates
KW  - economics
KW  - Acute Disease
KW  - Antibodies, Monoclonal
KW  - Coronary Disease
KW  - drug therapy
KW  - Drug Evaluation
KW  - Eptifibatide
KW  - Guidelines as Topic
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Incidence
KW  - Injections, Intravenous
KW  - Peptides
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Risk Assessment
KW  - Tirofiban
KW  - Treatment Outcome
KW  - Tyrosine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1517/14740338.2.1.49
ER  -